- 专利标题: Butylphthalide-telmisartan hybrids, preparation method and application thereof
-
申请号: US16478400申请日: 2018-01-04
-
公开(公告)号: US11028073B2公开(公告)日: 2021-06-08
- 发明人: Zhangjian Huang , Tao Pang , Cunfang Wang , Wenbin Zeng , Jinxiang Deng , Weijie Wu , Tingyu Huang
- 申请人: GUANGDONG LONGFU MEDICINE CO., LTD.
- 申请人地址: CN Zhongshan
- 专利权人: GUANGDONG LONGFU MEDICINE CO., LTD.
- 当前专利权人: GUANGDONG LONGFU MEDICINE CO., LTD.
- 当前专利权人地址: CN Zhongshan
- 代理机构: Kagan Binder, PLLC
- 优先权: CN201710033418.6 20170118
- 国际申请: PCT/CN2018/071308 WO 20180104
- 国际公布: WO2018/133670 WO 20180726
- 主分类号: C07D235/18
- IPC分类号: C07D235/18 ; C07D257/04 ; C07D403/10 ; C07D403/04 ; A61P9/10 ; A61P25/16 ; A61P29/00
摘要:
The invention discloses a butylphthalide-telmisartan heterocomplex, a preparation method and an application thereof. The invention specifically relates to an optically active ring-opening butylphthalide-telmisartan heterocomplex shown in formula I or a pharmaceutically acceptable salt or ester thereof, a preparation method thereof, a pharmaceutical composition containing the compounds, and a pharmaceutical application thereof, particularly application in prevention and treatment of neuroinflammation-related diseases, including ischemic stroke, Alzheimer's disease, brain trauma, Parkinson's disease, multiple sclerosis, depression and so on.
信息查询